Personalized medicine in pediatric cardiology: Do little changes make a big difference?

Current Opinion in Pediatrics

Volumn 24, Issue 5, 2012, Pages 584-591

  Manickaraj, Ashok K ^a   Mital, Seema ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Congenital heart disease; genomics; pediatric cardiology; personalized medicine; pharmacogenomics

Indexed keywords

ANTHRACYCLINE; BUCINDOLOL; CLOPIDOGREL; DNA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TACROLIMUS; WARFARIN;

ANEUPLOIDY; CARDIOTOXICITY; CHILD; CONGENITAL HEART DISEASE; DIAGNOSTIC ACCURACY; DRUG CHOICE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; GENOTYPE ENVIRONMENT INTERACTION; GRAFT REJECTION; HUMAN; HUMAN GENOME; MEDICAL DECISION MAKING; NEXT GENERATION SEQUENCING; PEDIATRIC CARDIOLOGY; PERSONALIZED MEDICINE; PHARMACOGENOMICS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SCREENING TEST; TREATMENT RESPONSE;

ALGORITHMS; CARDIOLOGY; CHILD; CHILD, PRESCHOOL; DECISION SUPPORT SYSTEMS, CLINICAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; GENOTYPE; HEART DEFECTS, CONGENITAL; HUMANS; INDIVIDUALIZED MEDICINE; INFANT; INFANT, NEWBORN; MALE; PEDIATRICS; PHARMACOGENETICS; RISK ASSESSMENT;

EID: 84866434141     PISSN: 10408703     EISSN: 1531698X     Source Type: Journal    
DOI: 10.1097/MOP.0b013e328357a4ea     Document Type: Review

References (32)

1. Li C. Personalized medicine: the promised land-are we there yet? Clin Genet 2011; 79:403-412.
2. Farra N, Manickaraj AK, Ellis J, Mital S. Personalized medicine in the genomics era: highlights from an international symposium on childhood heart disease. Future Cardiol 2012; 8:157-160.
3. Roden DM, Johnson JA, Kimmel SE, et al. Cardiovascular Pharmacoge-nomics. Circ Res 2011; 109:807-820.
4. Wessels MW, Willems PJ. Genetic factors in nonsyndromic congenital heart malformations. Clin Genet 2010; 78:103-123.
5. Greenway SC, Pereira AC, Lin JC, etal. De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet 2009; 41:931-935.
6. Stevens KN, Hakonarson H, Kim CE, et al. Common variation in ISL1 confers genetic susceptibility for human congenital heart disease. PLoS ONE 2010; 5:e10855.
7. Soemedi R, Topf A, Wilson IJ, et al. Phenotype-specific effect of chromosome 1q21.1 rearrangements and GJA5 duplications in 2436 congenital heart disease patients and 6760 controls. Hum Mol Genet 2012; 21:1513-1520.
8. Goodship JA, Hall D, Topf A, et al. Common variant in the PTPN11 gene contri-butes to the risk of tetralogy of Fallot. Circ Cardiovasc Genet 2012; 5:287
9. McBride KL, Zender GA, Fitzgerald-Butt SM, et al. Association of common variants in ERBB4 with congenital left ventricular outflow tract obstruction defects. Birth Defects Res A Clin Mol Teratol 2011; 91:162-168.
10. O'Roak BJ, Vives L, Girirajan S, et al. Sporadic autism exomes reveal a highly interconnected protein networkof denovo mutations. Nature 2012; 485:246
11. Arrington CB, Bleyl SB, Matsunami N, et al. Exome analysis of a family with pleiotropic congenital heart disease/clinical perspective. Circ Cardiovasc Genet 2012; 5:175-182.
12. Dewey FE, Pan S, Wheeler MT, et al. DNA Sequencing. Circulation 2012; 125:931-944.
13. Lau TK, Chan MK, Salome Lo PS, et al. Clinical utility of noninvasive fetal trisomy (NIFTY) test: early experience. J Matern Fetal Neonatal Med 2012. [Epub ahead of print]
14. Lau TK, Chen F, Pan X, et al. Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing. J Matern Fetal Neonatal Med 2012. [Epub ahead of print]
15. Zhu H, Kartiko S, Finnell RH. Importance of gene-environment interactions in the etiology of selected birth defects. Clin Genet 2009; 75:409-423.
16. Goldmuntz E, Woyciechowski S, Renstrom D, et al. Variants of folate metabolism genes and the risk of conotruncal cardiac defects. Circ Cardio-vasc Genet 2008; 1:126-132.
17. Long J, Lupo PJ, Goldmuntz E, Mitchell LE. Evaluation of heterogeneity in the association between congenital heart defects and variants of folate metabolism genes: conotruncal and left-sided cardiac defects. Birth Defects Res A Clin Mol Teratol 2011; 91:879-884.
18. Hsu DT, Zak V, Mahony L, et al. Enalapril in infants with single ventricle. Circulation 2010; 122:333-340.
19. Mital S, Chung WK, Colan SD, et al. Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle/clinical perspective. Circulation 2011; 123:2353-2362.
20. Jeewa A, Mertens L, Manlhiot C, et al. Hypoxia-inducible factor gene polymorphisms and right ventricular adaptation in children after tetralogy of fallot repair. Circulation 2010; 122:A17289.
21. Zhang H, Gong D-X, Zhang YJ, et al. Effect of mitochondrial aldehyde dehydrogenase-2 genotype on cardioprotection in patients with congenital heart disease. Eur Heart J 2012; 33:1606-1614.
22. Borgman KY, Smith AH, Owen JP, et al. A genetic contribution to risk for postoperative junctional ectopic tachycardia in children undergoing surgery for congenital heart disease. Heart Rhythm 2011; 8:1900-1904.
23. Auerbach SR, Manlhiot C, Reddy S, et al. Recipient genotype is a predictor of allograft cytokine expression and outcomes after pediatric cardiac transplantation. J Am Coll Cardiol 2009; 53:1909-1917.
24. Girnita DM, Brooks MM, Webber SA, et al. Genetic polymorphisms impact the risk of acute rejection in pediatric heart transplantation: a multi-institutional study. Transplantation 2008; 85:1632-1639; 10.1097/TP.0b013e3181722edc.
25. Twito T, Joseph J, Mociornita A, et al. The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients. J Heart Lung Transplant 2011; 30:778-782.
26. Snyder TM, Khush KK, Valantine HA, Quake SR. Universal noninvasive detection of solid organ transplant rejection. Proc Natl Acad Sci 2011; 108:6229-6234.
27. Visscher H, Amstutz U, Sistonen J, et al. Pharmacogenomics of cardiovascular drugs and adverse effects in pediatrics. J Cardiovasc Pharmacol 2011; 58:228-239.
28. Gijsen V, Mital S, van Schaik RH, et al. Age and CYP3A5 genotype affect tacrolimus dosing requirements after transplant in pediatric heart recipients. J Heart Lung Transplant 2011; 30:1352-1359.
29. Visscher H, Ross CJD, Rassekh SR, et al. Pharmacogenomic prediction of anthracycline-induced cardiotoxicity in children. J Clin Oncol 2012; 30:1422-1428.
30. Mital S. Personalizing medicine for the child with heart disease: a path forward. J Cardiovasc Pharmacol 2011; 58:1-3; 10.1097/FJC.0b013e3182239ed7.
31. Burchill L, Greenway S, Silversides C, Mital S. Genetic counseling in the adult with congenital heart disease: what is the role? Curr Cardiol Rep 2011; 13:347-355.
32. Ashley EA, Hershberger RE, Caleshu C, et al. Genetics and Cardiovascular Disease. Circulation 2012; 126:142-157.